P536: 2q11.2 recurrent CNVs including TMEM127: A collaborative multi-center study to expand knowledge of neurodevelopmental phenotypes and pheochromocytoma/paraganglioma syndrome predisposition

P536: 2q11.2 recurrent CNVs including TMEM127: A collaborative multi-center study to expand knowledge of neurodevelopmental phenotypes and pheochromocytoma/paraganglioma syndrome predisposition

Bibliographic Details
Main Authors:	Lucilla Pizzo, Zoe Lewis, Lauren Walsh, Cassandra Runke, Margit Nõukas, Katrin Männik, Neeme Tõnisson, Erik Thorland, Christa Martin, Katie Rudd, Erica Andersen
Format:	Article
Language:	English
Published:	Elsevier 2023-01-01
Series:	Genetics in Medicine Open
Online Access:	http://www.sciencedirect.com/science/article/pii/S2949774423005836

Similar Items

Spectrum and prevalence of FP/TMEM127 gene mutations in pheochromocytomas and paragangliomas.
by: Yao, L, et al.
Published: (2010)

Clinical observation of a patient with TMEM127 and EGLN1 gene variants, pheochromocytoma and pancreatic tumor
by: M. Yu. Yukina, et al.
Published: (2021-05-01)

Tumour microenvironment in pheochromocytoma and paraganglioma
by: Serena Martinelli, et al.
Published: (2023-03-01)

Pheochromocytoma (PHEO) and Paraganglioma (PGL)
by: Karel Pacak, et al.
Published: (2019-09-01)

Pheochromocytoma/paraganglioma-associated cardiomyopathy
by: Alicja Szatko, et al.
Published: (2023-07-01)

Characteristics of pediatric pheochromocytoma/paraganglioma
by: Vijaya Sarathi
Published: (2017-01-01)

Diagnosis for Pheochromocytoma and Paraganglioma: A Joint Position Statement of the Korean Pheochromocytoma and Paraganglioma Task Force
by: Eu Jeong Ku, et al.
Published: (2021-04-01)

Pheochromocytomas and paragangliomas: assessment of malignant potential
by: Korevaar, T, et al.
Published: (2011)

Pheochromocytomas and paragangliomas: assessment of malignant potential.
by: Korevaar, T, et al.
Published: (2011)

Cardiovascular Manifestations and Complications of Pheochromocytomas and Paragangliomas
by: Shams Y-Hassan, et al.
Published: (2020-07-01)

Potential Biomarkers of Metastasizing Paragangliomas and Pheochromocytomas
by: Anastasiya Snezhkina, et al.
Published: (2021-11-01)

Editorial: Predictive tools in pheochromocytoma and paraganglioma
by: Filippo Ceccato, et al.
Published: (2023-06-01)

Molecular Alterations in Dog Pheochromocytomas and Paragangliomas
by: Esther Korpershoek, et al.
Published: (2019-04-01)

Postoperative Management in Patients with Pheochromocytoma and Paraganglioma
by: Divya Mamilla, et al.
Published: (2019-07-01)

Pheochromocytomas and Paragangliomas: Bypassing Cellular Respiration
by: Alberto Cascón, et al.
Published: (2019-05-01)

Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma
by: Fishbein, Lauren, et al.
Published: (2018)

Update on Modern Management of Pheochromocytoma and Paraganglioma
by: Jacques W. M. Lenders, et al.
Published: (2017-06-01)

Cancer Stem Cells in Pheochromocytoma and Paraganglioma
by: Laura D. Scriba, et al.
Published: (2020-02-01)

Genetics of Pheochromocytomas and Paragangliomas Determine the Therapeutical Approach
by: Balazs Sarkadi, et al.
Published: (2022-01-01)

Pheochromocytomas and Abdominal Paragangliomas: A Practical Guidance
by: Jan Calissendorff, et al.
Published: (2022-02-01)

The Clinical Characteristics of Pheochromocytomas and Paragangliomas with Negative Catecholamines
by: Lin Zhao, et al.
Published: (2022-09-01)

Metyrosine-associated endocrinological changes in pheochromocytoma and paraganglioma
by: Yuko Matsuo, et al.
Published: (2023-10-01)

Genomic and immune landscape Of metastatic pheochromocytoma and paraganglioma
by: Bruna Calsina, et al.
Published: (2023-02-01)

Whole transcriptome analysis of canine pheochromocytoma and paraganglioma
by: Marit F. van den Berg, et al.
Published: (2023-08-01)

Chromogranin A in the Laboratory Diagnosis of Pheochromocytoma and Paraganglioma
by: Radovan Bílek, et al.
Published: (2019-04-01)

FGF21 Levels in Pheochromocytoma/Functional Paraganglioma
by: Judita Klímová, et al.
Published: (2019-04-01)

Clinical presentation of sporadic and hereditary pheochromocytoma/paraganglioma
by: Sofia Maria Lider Burciulescu, et al.
Published: (2023-02-01)

Pheochromocytoma and paraganglioma: germline genetics and hereditary syndromes
by: Christie G Turin, et al.
Published: (2023-01-01)

Initial characterization of immune microenvironment in pheochromocytoma and paraganglioma
by: Bo Jin, et al.
Published: (2022-12-01)

Signaling pathways in pheochromocytomas and paragangliomas: prospects for future therapies.
by: Nölting, S, et al.
Published: (2012)

Local recurrence and metastatic disease in pheochromocytomas and sympathetic paragangliomas
by: Marta Araujo-Castro, et al.
Published: (2023-12-01)

Hypermetabolism and Substrate Utilization Rates in Pheochromocytoma and Functional Paraganglioma
by: Ondřej Petrák, et al.
Published: (2022-08-01)

Efficacy of Immunohistochemistry for SDHB in the Screening of Hereditary Pheochromocytoma–Paraganglioma
by: Hye-Ryeon Choi, et al.
Published: (2021-07-01)

Gene Profile of Adipose Tissue of Patients with Pheochromocytoma/Paraganglioma
by: Judita Klímová, et al.
Published: (2022-03-01)

Pheochromocytomas and Paragangliomas: From Genetic Diversity to Targeted Therapies
by: Ying Pang, et al.
Published: (2019-03-01)

The Pheochromocytoma/Paraganglioma syndrome: an overview on mechanisms, diagnosis and management
by: José Viana Lima Junior, et al.
Published: (2023-06-01)

Surgical strategies of complicated pheochromocytomas/paragangliomas and literature review
by: Xu Wang, et al.
Published: (2023-04-01)

Circulating GLP-1 Levels in Patients with Pheochromocytoma/Paraganglioma
by: Nan Chen, et al.
Published: (2022-01-01)

Clinical differences between small and large pheochromocytomas and paragangliomas
by: Lin Zhao, et al.
Published: (2023-03-01)

Challenging anesthesia in pediatric pheochromocytoma and paraganglioma tumors resection
by: Putu Kurniyanta, et al.
Published: (2021-01-01)